Erratum: FOXO3 A master switch for regulating tolerance and immunity in dendritic cells (OncoImmunology, (2012), 1, 2, (252-254), 10.4161/onci.1.2.18241);FOXO3: A master switch for regulating tolerance and immunity in dendritic cells

OncoImmunology

Volumn 1, Issue 2, 2012, Pages 252-254

  Watkins, Stephanie K ^a   Hurwitz, Arthur A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Dendritic cells; Foxo3; Immunotherapy; Tolerance; Tumor

Indexed keywords

ARGINASE; B7 ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 6; TRANSCRIPTION FACTOR FKHRL1; TRANSFORMING GROWTH FACTOR BETA;

CD8+ T LYMPHOCYTE; DENDRITIC CELL; DNA BINDING; FOXO3 GENE; GENE; GENE EXPRESSION; GENE SILENCING; GENE SWITCHING; GENETIC ANALYSIS; HUMAN; IMMUNOLOGICAL TOLERANCE; INDOLEAMINE 2,3 DIOXYGENASE GENE; INTERLEUKIN 10 GENE; NONHUMAN; NOTE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEIN MOTIF; TRANSFORMING GROWTH FACTOR BETA GENE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT;

EID: 84878643583     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2016.1173506     Document Type: Erratum

References (10)

1. Anderson MJ, Shafer-Weaver K, Greenberg NM, Hurwitz AA. Tolerization of tumor-specific T cells despite efficient initial priming in a primary murine model of prostate cancer. J Immunol 2007; 178:1268-76
2. Pinzon-Charry A, Maxwell T, Lopez JA. Dendritic cell dysfunction in cancer: a mechanism for immunosuppression. Immunol Cell Biol 2005; 83:451-61; http://dx.doi.org/10.1111/j.1440-1711.2005.01371.x
3. Shafer-Weaver KA., Hurwitz AA. Cutting Edge: Tumor-specific CD8+ T Cells infiltrating prostatic tumors are induced to become suppressor cells. J Immunol 2009; 183:4848-52.
4. Watkins SK, Zhu Z, Riboldi E, Shafer-Weaver KA, Stagliano KER, Sklavos MM, et al. Foxo3a programs tumor associated dendritic cells to become tolerogenic in Human and Murine Prostate Cancer. J Clin Invest 2011; 121:1361-72; http://dx.doi.org/10.1172/JCI44325
5. Dejean AS, Beisner DR, Ch'en IL, Kerdiles YM, Babour A, Arden KC, et al. Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells. Nat Immunol 2009; 10:504-13; http://dx.doi.org/10.1038/ni.1729
6. Shafer-Weaver KA, Watkins SK, Anderson MK, Draper LJ, Malyguine A, Alvord WG, et al. Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells. Cancer Res 2009; 69:6256-64; http://dx.doi.org/10.1158/0008-5472.CAN-08-4516
7. Nakamura T, Sakamoto K. Forkhead transcription factor FOXO subfamily is essential for reactive oxygen species-induced apoptosis. Mol Cell Endocrinol 2008; 281:47-55; http://dx.doi.org/10.1016/j.mce.2007.10.007
8. Lin L, Hron JD, Peng SL. Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 2004; 21:203-13; http://dx.doi.org/10.1016/j.immuni.2004.06.016
9. Komarova EA, Krivokrysenko V, Wang K, Neznanov N, Chernov MV, Komarov PG, et al. p53 is a suppressor of inflammatory response in mice. FASEB J 2005; 19:1030-2.
10. Dijkers PF, Medema RH, Lammers JW, Koenderman L, Coffer PJ. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 2000; 10: 1201-4; http://dx.doi.org/10.1016/S0960-9822(00)00728-4